Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart Disease
Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction...
Saved in:
Published in | The American journal of cardiology Vol. 103; no. 4; pp. 476 - 481 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
15.02.2009
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = −0.23, p = 0.002) and apolipoprotein A1 (R = −0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD. |
---|---|
AbstractList | Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = −0.23, p = 0.002) and apolipoprotein A1 (R = −0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD. Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = -0.23, p = 0.002) and apolipoprotein A1 (R = -0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD. Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = -0.23, p = 0.002) and apolipoprotein A1 (R = -0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD.Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest levels. Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = -0.23, p = 0.002) and apolipoprotein A1 (R = -0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD. Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart disease (CHD) and systemic cathepsin L levels remains unknown. A total of 137 volunteers with diagnosed acute and previous myocardial infarction (MI) and stable and unstable angina pectoris in addition to 48 controls were asked to undergo coronary angiography. Serum cathepsin L, high-sensitivity C-reactive protein, fasting glucose, and lipid protein profiles were measured. Serum cathepsin L levels were significantly higher in patients with CHD than in those without CHD (p <0.001). The significance persisted after adjusting for most major confounders. Patients with unstable angina pectoris had higher serum cathepsin L levels than those with stable angina pectoris (p = 0.02). Of patients with acute coronary syndrome, those with acute MI had higher serum cathepsin L levels than those with unstable angina pectoris (p <0.05) and patients with previous MI had the highest leve Importantly, serum cathepsin L associated positively with number of coronary branch luminal narrowings (R = 0.38, p <0.001), Gensini scores (R = 0.44, p <0.001), high-sensitivity C-reactive protein (R = 0.32, p <0.001), fasting glucose (R = 0.16, p <0.03), and cigarette smokers (R = 0.27, p <0.001), but inversely with high-density lipoprotein (R = -0.23, p = 0.002) and apolipoprotein A1 (R = -0.19, p = 0.01) in all subjects. In conclusion, after adjusting for these confounders, we found that serum cathepsin L correlated positively and independently with Gensini score, suggesting that serum cathepsin L serves as a novel and independent biomarker for CHD. [PUBLICATION ABSTRACT] |
Author | Peng, Daoquan Xue, Yanqiong Tan, Zheng Shi, Guo-Ping Liu, Yingxian Li, Xiangping Liu, Hongmin Qing, Yingnan |
AuthorAffiliation | a Department of Medicine, Peking Union Medical College Hospital, Beijing, Central South University, Hunan, China b Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China c Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts |
AuthorAffiliation_xml | – name: b Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China – name: c Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts – name: a Department of Medicine, Peking Union Medical College Hospital, Beijing, Central South University, Hunan, China |
Author_xml | – sequence: 1 givenname: Yingxian surname: Liu fullname: Liu, Yingxian organization: Department of Medicine, Peking Union Medical College Hospital, Beijing, China – sequence: 2 givenname: Xiangping surname: Li fullname: Li, Xiangping organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China – sequence: 3 givenname: Daoquan surname: Peng fullname: Peng, Daoquan organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China – sequence: 4 givenname: Zheng surname: Tan fullname: Tan, Zheng organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China – sequence: 5 givenname: Hongmin surname: Liu fullname: Liu, Hongmin organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China – sequence: 6 givenname: Yingnan surname: Qing fullname: Qing, Yingnan organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China – sequence: 7 givenname: Yanqiong surname: Xue fullname: Xue, Yanqiong organization: Department of Cardiology, Second Xiangya Hospital, Central South University, Hunan, China – sequence: 8 givenname: Guo-Ping surname: Shi fullname: Shi, Guo-Ping email: gshi@rics.bwh.harvard.edu organization: Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21139717$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19195505$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUl2LEzEUDbLidld_ghIEfZuam_nIBHFF68cuFBTWxceQZu7YdKdJTWYW-u_N0Fq0IOtLQm7OOZx77zkjJ847JOQpsCkwqF6tpnq9Mjo0U85YnWpTBvCATKAWMgMJ-QmZMMZ4JqGQp-QsxlV6ApTVI3Ka_mVZsnJCzE3Edugcxkh9S68xDGs60_0SN9E6Oqc6Uu3olWtwg-lwPX1v_VqHWww0Ab7q3qZipN9tv6QzH7zTYUsvUYeefrARdcTH5GGru4hP9vc5ufn08dvsMpt_-Xw1ezfPTJVDnxWykHVhCi2rSoNYgGhZUehFW7RNXUNdNu2CgxamKaBiLM9BIC-NLFGWDS_z_Jxc7HQ3w2KNjUm-gu7UJtjkd6u8turvH2eX6oe_U1yUvKpGgZd7geB_Dhh7tbbRYNdph36IqqpqyYFVCfj8CLjyQ3CpOcVzlgsBuUigZ3_aOfj4PfwEeLEH6Gh01wbtjI0HHAfIpYBR6PUOZ4KPMWCrjO3T3P3Yhe0UMDVGQq3UPhJqjMRYTvtO7PKIfTByD-_tjodpZXcWg4omrdpgYwOaXjXe3qtwcaRgOutsavUWtxgPIwMVuWLqeozrmFZWM6hrwZLAm38L_IeBX5vr-88 |
CODEN | AJCDAG |
CitedBy_id | crossref_primary_10_3892_ol_2019_11067 crossref_primary_10_2991_artres_k_191125_001 crossref_primary_10_1002_jcla_23608 crossref_primary_10_5005_jp_journals_10024_1019 crossref_primary_10_1016_j_cellsig_2020_109770 crossref_primary_10_1590_S0100_879X2010005000008 crossref_primary_10_1186_s13104_017_2940_y crossref_primary_10_1155_2018_3091424 crossref_primary_10_1038_s41569_018_0002_3 crossref_primary_10_1016_j_jss_2019_06_102 crossref_primary_10_1002_prca_201300085 crossref_primary_10_1161_HYPERTENSIONAHA_124_22903 crossref_primary_10_3736_jcim20100908 crossref_primary_10_1039_c2ib20197f crossref_primary_10_1161_CIRCULATIONAHA_111_066712 crossref_primary_10_4068_cmj_2012_48_2_77 crossref_primary_10_1093_cvr_cvab204 crossref_primary_10_1016_j_bmcl_2012_09_086 crossref_primary_10_1038_srep13855 crossref_primary_10_1371_journal_pone_0187494 crossref_primary_10_3892_etm_2019_8222 crossref_primary_10_1016_j_atherosclerosis_2011_02_016 crossref_primary_10_1161_HYPERTENSIONAHA_111_180935 crossref_primary_10_1016_j_atherosclerosis_2015_06_017 crossref_primary_10_1186_1479_5876_9_109 crossref_primary_10_1016_j_biochi_2015_10_010 crossref_primary_10_1039_c3ob41341a crossref_primary_10_1039_D1OB00225B crossref_primary_10_1016_j_bbapap_2020_140360 crossref_primary_10_1016_j_atherosclerosis_2016_09_062 crossref_primary_10_1007_s11010_016_2924_6 crossref_primary_10_1093_cvr_cvq328 crossref_primary_10_1002_oby_22660 crossref_primary_10_1016_j_biochi_2010_03_011 crossref_primary_10_1016_j_ijbiomac_2020_11_185 crossref_primary_10_1097_FJC_0000000000000522 crossref_primary_10_1007_s10142_024_01391_2 crossref_primary_10_1016_j_bbadis_2014_04_032 crossref_primary_10_1016_j_yjmcc_2018_11_010 crossref_primary_10_1002_cmdc_202000823 crossref_primary_10_1177_147323001003800421 crossref_primary_10_3349_ymj_2014_55_4_912 crossref_primary_10_1016_j_peptides_2013_01_011 |
Cites_doi | 10.1161/01.CIR.92.8.2127 10.1016/S0735-1097(00)00804-4 10.1161/01.ATV.0000227470.72109.2b 10.1016/S0033-8389(22)02831-7 10.1016/j.atherosclerosis.2005.05.012 10.1016/j.vetpar.2005.10.016 10.1126/science.280.5362.450 10.1016/j.atherosclerosis.2005.08.001 10.1016/S0002-9149(83)80105-2 10.1172/JCI181 10.1161/01.ATV.0000134530.27208.41 10.1093/ndt/gfh374 10.1111/j.1600-065X.1999.tb01360.x 10.1096/fj.05-5517fje 10.2353/ajpath.2008.071126 10.1016/j.atherosclerosis.2006.11.013 10.1161/CIRCULATIONAHA.107.688523 10.1536/jhj.43.607 10.1146/annurev.physiol.59.1.63 10.1016/S1535-6108(04)00111-4 10.1161/01.CIR.80.2.410 10.1038/nm1182 10.1136/jcp.2006.038729 10.1359/jbmr.060614 10.1196/annals.1329.053 10.1111/j.1582-4934.2004.tb00469.x 10.1073/pnas.092637699 |
ContentType | Journal Article |
Copyright | 2009 Elsevier Inc. Elsevier Inc. 2009 INIST-CNRS Copyright Elsevier Sequoia S.A. Feb 15, 2009 2009 Elsevier Inc. 2009 |
Copyright_xml | – notice: 2009 Elsevier Inc. – notice: Elsevier Inc. – notice: 2009 INIST-CNRS – notice: Copyright Elsevier Sequoia S.A. Feb 15, 2009 – notice: 2009 Elsevier Inc. 2009 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7TS 8FD FR3 K9. M7Z NAPCQ P64 7X8 5PM |
DOI | 10.1016/j.amjcard.2008.10.011 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Physical Education Index Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biochemistry Abstracts 1 Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Technology Research Database Biochemistry Abstracts 1 ProQuest Health & Medical Complete (Alumni) Engineering Research Database Physical Education Index Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Nursing & Allied Health Premium |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-1913 |
EndPage | 481 |
ExternalDocumentID | PMC2752663 1643440011 19195505 21139717 10_1016_j_amjcard_2008_10_011 S0002914908018870 1_s2_0_S0002914908018870 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL067283 – fundername: NHLBI NIH HHS grantid: R01 HL081090 – fundername: NHLBI NIH HHS grantid: HL81090 – fundername: NHLBI NIH HHS grantid: HL60942 – fundername: NHLBI NIH HHS grantid: HL67283 – fundername: NHLBI NIH HHS grantid: R01 HL060942 |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1CY 1P~ 1RT 1~. 1~5 23M 3O- 4.4 457 4G. 53G 5RE 5VS 6J9 7-5 71M 7RV 7X7 88E 8FI 8FJ 8G5 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAQFI AAQQT AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABPPZ ABUWG ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACIWK ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADUKH AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN AZQEC BENPR BKEYQ BKOJK BKOMP BLXMC BNPGV BPHCQ BVXVI CCPQU CS3 DWQXO EBS EFJIC EFKBS EJD EMOBN EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HEB HMCUK HMK HMO HVGLF HZ~ IH2 IHE J1W J5H K-O KOM L7B M1P M29 M2O M41 MO0 N9A NAPCQ O-L O9- OA. OAUVE OHT OL~ OVD OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q38 R2- ROL RPZ SAE SDF SDG SEL SES SJN SPCBC SSH SSZ SV3 T5K TEORI TWZ UKHRP UNMZH UV1 WH7 WOW WUQ X7M XPP YFH YOC YQJ YYP YZZ Z5R ZGI ZXP ~G- 3V. AACTN AAYOK AFCTW AFKWA AJOXV ALIPV AMFUW PKN RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7TS 8FD FR3 K9. M7Z P64 7X8 5PM |
ID | FETCH-LOGICAL-c631t-494984c4a966a17b17f044abf4fd88185dfb21a7cd416003317e25c95e95d2533 |
IEDL.DBID | AIKHN |
ISSN | 0002-9149 1879-1913 |
IngestDate | Thu Aug 21 14:36:01 EDT 2025 Thu Aug 07 15:31:02 EDT 2025 Sat Jul 26 02:24:21 EDT 2025 Mon Jul 21 06:06:10 EDT 2025 Mon Jul 21 09:14:52 EDT 2025 Tue Jul 01 01:52:41 EDT 2025 Thu Apr 24 23:03:49 EDT 2025 Fri Feb 23 02:27:28 EST 2024 Sun Feb 23 10:19:00 EST 2025 Tue Aug 26 18:33:33 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Human Peptidases Cathepsin L Enzyme Cysteine endopeptidases Biological marker Hydrolases Cardiovascular disease Serum Circulatory system Cardiology Coronary heart disease |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c631t-494984c4a966a17b17f044abf4fd88185dfb21a7cd416003317e25c95e95d2533 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Corresponding author: Tel: 617-525-4358; or 86-139-7-487-9019 (X. Li); fax: 617-525-4380. E-mail address: gshi@rics.bwh.harvard.edu (G.-P. Shi). |
OpenAccessLink | http://doi.org/10.1016/j.amjcard.2008.10.011 |
PMID | 19195505 |
PQID | 230377137 |
PQPubID | 41200 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2752663 proquest_miscellaneous_66892106 proquest_journals_230377137 pubmed_primary_19195505 pascalfrancis_primary_21139717 crossref_citationtrail_10_1016_j_amjcard_2008_10_011 crossref_primary_10_1016_j_amjcard_2008_10_011 elsevier_sciencedirect_doi_10_1016_j_amjcard_2008_10_011 elsevier_clinicalkeyesjournals_1_s2_0_S0002914908018870 elsevier_clinicalkey_doi_10_1016_j_amjcard_2008_10_011 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-02-15 |
PublicationDateYYYYMMDD | 2009-02-15 |
PublicationDate_xml | – month: 02 year: 2009 text: 2009-02-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: New York |
PublicationTitle | The American journal of cardiology |
PublicationTitleAlternate | Am J Cardiol |
PublicationYear | 2009 |
Publisher | Elsevier Inc Elsevier Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
References | Liu, Sukhova, Sun, Xu, Libby, Shi (bib19) 2004; 24 Joyce, Baruch, Chehade, Meyer-Morse, Giraudo, Tsai, Greenbaum, Hager, Bogyo, Hanahan (bib9) 2004; 5 Sriveny, Raina, Yadav, Chandra, Jayraw, Singh, Velusamy, Singh (bib12) 2006; 135 Geluk, Post, Hillege, Tio, Tijssen, van Dijk, Dijk, Bakker, de Jong, van Gilst, Zijlstra (bib24) 2008; 196 Vonend, Apel, Amann, Sellin, Stegbauer, Ritz, Rump (bib10) 2004; 19 Sukhova, Shi, Simon, Chapman, Libby (bib6) 1998; 102 Braunward (bib15) 1989; 80 Urbich, Heeschen, Aicher, Sasaki, Bruhl, Farhadi, Vajkoczy, Hofmann, Peters, Pennacchio (bib3) 2005; 11 Kitamoto, Sukhova, Sun, Yang, Libby, Love, Duramad, Sun, Zhang, Yang, Peters, Shi (bib5) 2007; 115 Everts, Korper, Hoeben, Jansen, Bromme, Cleutjens, Heeneman, Peters, Reinheckel, Saftig, Beertsen (bib13) 2006; 21 Liu, Sukhova, Yang, Sun, Ma, Ren, Xu, Fu, Dolganov, Hu, Libby, Shi (bib1) 2006; 184 Gensini (bib17) 1983; 51 Adams, Nakagomi, Keech, Robinson, McCredie, Bailey, Freedman, Celermajer (bib20) 1995; 92 Auer, Berent, Lassnig, Eber (bib18) 2002; 43 Villadangos, Bryant, Deussing, Driessen, Lennon-Duménil, Riese, Roth, Saftig, Shi, Chapman, Peters, Ploegh (bib8) 1999; 172 Li, Yuan (bib2) 2004; 1030 Stypmann, Gläser, Roth, Tobin, Petermann, Matthias, Mönnig, Haverkamp, Breithardt, Schmahl, Peters, Reinheckel (bib27) 2002; 99 Cheng, Murohara, Kuzuya, Izawa, Sasaki, Obata, Nagata, Nishizawa, Kobayashi, Yamada (bib22) 2008; 173 Norja, Nuutila, Karhunen, Goebeler (bib23) 2007; 60 Ding, Yin (bib11) 2004; 8 Petermann, Mayer, Stypmann, Biniossek, Tobin, Engelen, Dandekar, Grune, Schild, Peters, Reinheckel (bib26) 2006; 20 Chapman, Riese, Shi (bib7) 1997; 59 Liu, Ma, Yang, Ren, Sun, Yan, Sun, Fu, Xu, Hu, Shi (bib25) 2006; 186 Alpert, Thygesen, Antman, Bassand (bib14) 2000; 36 Platt, Ankeny, Jo (bib21) 2006; 26 Nakagawa, Roth, Wong, Nelson, Farr, Deussing, Villadangos, Ploegh, Peters, Rudensky (bib4) 1998; 280 Judkins (bib16) 1968; 6 Joyce (10.1016/j.amjcard.2008.10.011_bib9) 2004; 5 Gensini (10.1016/j.amjcard.2008.10.011_bib17) 1983; 51 Everts (10.1016/j.amjcard.2008.10.011_bib13) 2006; 21 Sriveny (10.1016/j.amjcard.2008.10.011_bib12) 2006; 135 Petermann (10.1016/j.amjcard.2008.10.011_bib26) 2006; 20 Villadangos (10.1016/j.amjcard.2008.10.011_bib8) 1999; 172 Platt (10.1016/j.amjcard.2008.10.011_bib21) 2006; 26 Auer (10.1016/j.amjcard.2008.10.011_bib18) 2002; 43 Liu (10.1016/j.amjcard.2008.10.011_bib19) 2004; 24 Liu (10.1016/j.amjcard.2008.10.011_bib1) 2006; 184 Li (10.1016/j.amjcard.2008.10.011_bib2) 2004; 1030 Vonend (10.1016/j.amjcard.2008.10.011_bib10) 2004; 19 Braunward (10.1016/j.amjcard.2008.10.011_bib15) 1989; 80 Geluk (10.1016/j.amjcard.2008.10.011_bib24) 2008; 196 Liu (10.1016/j.amjcard.2008.10.011_bib25) 2006; 186 Nakagawa (10.1016/j.amjcard.2008.10.011_bib4) 1998; 280 Sukhova (10.1016/j.amjcard.2008.10.011_bib6) 1998; 102 Adams (10.1016/j.amjcard.2008.10.011_bib20) 1995; 92 Kitamoto (10.1016/j.amjcard.2008.10.011_bib5) 2007; 115 Ding (10.1016/j.amjcard.2008.10.011_bib11) 2004; 8 Cheng (10.1016/j.amjcard.2008.10.011_bib22) 2008; 173 Stypmann (10.1016/j.amjcard.2008.10.011_bib27) 2002; 99 Alpert (10.1016/j.amjcard.2008.10.011_bib14) 2000; 36 Chapman (10.1016/j.amjcard.2008.10.011_bib7) 1997; 59 Urbich (10.1016/j.amjcard.2008.10.011_bib3) 2005; 11 Judkins (10.1016/j.amjcard.2008.10.011_bib16) 1968; 6 Norja (10.1016/j.amjcard.2008.10.011_bib23) 2007; 60 |
References_xml | – volume: 92 start-page: 2127 year: 1995 end-page: 2134 ident: bib20 article-title: Carotid intima–media thickness is only weakly correlated with the extent and severity of coronary artery disease publication-title: Circulation – volume: 43 start-page: 607 year: 2002 end-page: 619 ident: bib18 article-title: C-reactive protein and coronary artery disease publication-title: Jpn Heart J – volume: 24 start-page: 1359 year: 2004 end-page: 1366 ident: bib19 article-title: Lysosomal cysteine proteases in atherosclerosis publication-title: Arterioscler Thromb Vasc Biol – volume: 186 start-page: 411 year: 2006 end-page: 419 ident: bib25 article-title: Increased serum cathepsin S in patients with atherosclerosis and diabetes publication-title: Atherosclerosis – volume: 102 start-page: 576 year: 1998 end-page: 583 ident: bib6 article-title: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells publication-title: J Clin Invest – volume: 60 start-page: 545 year: 2007 end-page: 548 ident: bib23 article-title: C-reactive protein in vulnerable coronary plaques publication-title: J Clin Pathol – volume: 20 start-page: 1266 year: 2006 end-page: 1268 ident: bib26 article-title: Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice publication-title: FASEB J – volume: 99 start-page: 6234 year: 2002 end-page: 6239 ident: bib27 article-title: Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L publication-title: Proc Natl Acad Sci U S A – volume: 11 start-page: 206 year: 2005 end-page: 213 ident: bib3 article-title: Cathepsin L is required for endothelial progenitor cell-induced neovascularization publication-title: Nat Med – volume: 280 start-page: 394 year: 1998 end-page: 395 ident: bib4 article-title: Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus publication-title: Science – volume: 21 start-page: 1399 year: 2006 end-page: 1408 ident: bib13 article-title: Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone publication-title: Bone Miner Res – volume: 26 start-page: 1784 year: 2006 end-page: 1790 ident: bib21 article-title: Laminar shear stress inhibits cathepsin L activity in endothelial cells publication-title: Arterioscler Thromb Vasc Biol – volume: 51 start-page: 606 year: 1983 ident: bib17 article-title: A more meaningful scoring system for determining the severity of coronary heart disease publication-title: Am J Cardiol – volume: 196 start-page: 372 year: 2008 end-page: 382 ident: bib24 article-title: C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort publication-title: Atherosclerosis – volume: 135 start-page: 25 year: 2006 end-page: 31 ident: bib12 article-title: Cathepsin L cysteine proteinase in the diagnosis of bovine Fasciola gigantica infection publication-title: Vet Parasitol – volume: 59 start-page: 63 year: 1997 end-page: 88 ident: bib7 article-title: Emerging roles for cysteine proteases in human biology publication-title: Annu Rev Physiol – volume: 173 start-page: 358 year: 2008 end-page: 369 ident: bib22 article-title: Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment publication-title: Am J Pathol – volume: 36 start-page: 959 year: 2000 end-page: 969 ident: bib14 article-title: Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction publication-title: J Am Coll Cardiol – volume: 8 start-page: 445 year: 2004 end-page: 454 ident: bib11 article-title: Dissection of the multiple mechanisms of TNF-alpha–induced apoptosis in liver injury publication-title: J Cell Mol Med – volume: 172 start-page: 109 year: 1999 end-page: 120 ident: bib8 article-title: Proteases involved in MHC class II antigen presentation publication-title: Immunol Rev – volume: 184 start-page: 302 year: 2006 end-page: 311 ident: bib1 article-title: Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells publication-title: Atherosclerosis – volume: 1030 start-page: 427 year: 2004 end-page: 433 ident: bib2 article-title: Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis publication-title: Ann N Y Acad Sci – volume: 5 start-page: 443 year: 2004 end-page: 453 ident: bib9 article-title: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis publication-title: Cancer Cell – volume: 6 start-page: 467 year: 1968 end-page: 492 ident: bib16 article-title: Percutaneous transfemoral selective coronary arteriography publication-title: Radiol Clin North Am – volume: 115 start-page: 2065 year: 2007 end-page: 2075 ident: bib5 article-title: Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice publication-title: Circulation – volume: 80 start-page: 410 year: 1989 end-page: 414 ident: bib15 article-title: Unstable angina: a classification publication-title: Circulation – volume: 19 start-page: 2217 year: 2004 end-page: 2222 ident: bib10 article-title: Modulation of gene expression by moxonidine in rats with chronic renal failure publication-title: Nephrol Dial Transplant – volume: 92 start-page: 2127 year: 1995 ident: 10.1016/j.amjcard.2008.10.011_bib20 article-title: Carotid intima–media thickness is only weakly correlated with the extent and severity of coronary artery disease publication-title: Circulation doi: 10.1161/01.CIR.92.8.2127 – volume: 36 start-page: 959 year: 2000 ident: 10.1016/j.amjcard.2008.10.011_bib14 article-title: Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(00)00804-4 – volume: 26 start-page: 1784 year: 2006 ident: 10.1016/j.amjcard.2008.10.011_bib21 article-title: Laminar shear stress inhibits cathepsin L activity in endothelial cells publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000227470.72109.2b – volume: 6 start-page: 467 year: 1968 ident: 10.1016/j.amjcard.2008.10.011_bib16 article-title: Percutaneous transfemoral selective coronary arteriography publication-title: Radiol Clin North Am doi: 10.1016/S0033-8389(22)02831-7 – volume: 184 start-page: 302 year: 2006 ident: 10.1016/j.amjcard.2008.10.011_bib1 article-title: Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2005.05.012 – volume: 135 start-page: 25 year: 2006 ident: 10.1016/j.amjcard.2008.10.011_bib12 article-title: Cathepsin L cysteine proteinase in the diagnosis of bovine Fasciola gigantica infection publication-title: Vet Parasitol doi: 10.1016/j.vetpar.2005.10.016 – volume: 280 start-page: 394 year: 1998 ident: 10.1016/j.amjcard.2008.10.011_bib4 article-title: Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus publication-title: Science doi: 10.1126/science.280.5362.450 – volume: 186 start-page: 411 year: 2006 ident: 10.1016/j.amjcard.2008.10.011_bib25 article-title: Increased serum cathepsin S in patients with atherosclerosis and diabetes publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2005.08.001 – volume: 51 start-page: 606 year: 1983 ident: 10.1016/j.amjcard.2008.10.011_bib17 article-title: A more meaningful scoring system for determining the severity of coronary heart disease publication-title: Am J Cardiol doi: 10.1016/S0002-9149(83)80105-2 – volume: 102 start-page: 576 year: 1998 ident: 10.1016/j.amjcard.2008.10.011_bib6 article-title: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells publication-title: J Clin Invest doi: 10.1172/JCI181 – volume: 24 start-page: 1359 year: 2004 ident: 10.1016/j.amjcard.2008.10.011_bib19 article-title: Lysosomal cysteine proteases in atherosclerosis publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000134530.27208.41 – volume: 19 start-page: 2217 year: 2004 ident: 10.1016/j.amjcard.2008.10.011_bib10 article-title: Modulation of gene expression by moxonidine in rats with chronic renal failure publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfh374 – volume: 172 start-page: 109 year: 1999 ident: 10.1016/j.amjcard.2008.10.011_bib8 article-title: Proteases involved in MHC class II antigen presentation publication-title: Immunol Rev doi: 10.1111/j.1600-065X.1999.tb01360.x – volume: 20 start-page: 1266 year: 2006 ident: 10.1016/j.amjcard.2008.10.011_bib26 article-title: Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice publication-title: FASEB J doi: 10.1096/fj.05-5517fje – volume: 173 start-page: 358 year: 2008 ident: 10.1016/j.amjcard.2008.10.011_bib22 article-title: Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment publication-title: Am J Pathol doi: 10.2353/ajpath.2008.071126 – volume: 196 start-page: 372 year: 2008 ident: 10.1016/j.amjcard.2008.10.011_bib24 article-title: C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.11.013 – volume: 115 start-page: 2065 year: 2007 ident: 10.1016/j.amjcard.2008.10.011_bib5 article-title: Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.688523 – volume: 43 start-page: 607 year: 2002 ident: 10.1016/j.amjcard.2008.10.011_bib18 article-title: C-reactive protein and coronary artery disease publication-title: Jpn Heart J doi: 10.1536/jhj.43.607 – volume: 59 start-page: 63 year: 1997 ident: 10.1016/j.amjcard.2008.10.011_bib7 article-title: Emerging roles for cysteine proteases in human biology publication-title: Annu Rev Physiol doi: 10.1146/annurev.physiol.59.1.63 – volume: 5 start-page: 443 year: 2004 ident: 10.1016/j.amjcard.2008.10.011_bib9 article-title: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis publication-title: Cancer Cell doi: 10.1016/S1535-6108(04)00111-4 – volume: 80 start-page: 410 year: 1989 ident: 10.1016/j.amjcard.2008.10.011_bib15 article-title: Unstable angina: a classification publication-title: Circulation doi: 10.1161/01.CIR.80.2.410 – volume: 11 start-page: 206 year: 2005 ident: 10.1016/j.amjcard.2008.10.011_bib3 article-title: Cathepsin L is required for endothelial progenitor cell-induced neovascularization publication-title: Nat Med doi: 10.1038/nm1182 – volume: 60 start-page: 545 year: 2007 ident: 10.1016/j.amjcard.2008.10.011_bib23 article-title: C-reactive protein in vulnerable coronary plaques publication-title: J Clin Pathol doi: 10.1136/jcp.2006.038729 – volume: 21 start-page: 1399 year: 2006 ident: 10.1016/j.amjcard.2008.10.011_bib13 article-title: Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone publication-title: Bone Miner Res doi: 10.1359/jbmr.060614 – volume: 1030 start-page: 427 year: 2004 ident: 10.1016/j.amjcard.2008.10.011_bib2 article-title: Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1329.053 – volume: 8 start-page: 445 year: 2004 ident: 10.1016/j.amjcard.2008.10.011_bib11 article-title: Dissection of the multiple mechanisms of TNF-alpha–induced apoptosis in liver injury publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2004.tb00469.x – volume: 99 start-page: 6234 year: 2002 ident: 10.1016/j.amjcard.2008.10.011_bib27 article-title: Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.092637699 |
SSID | ssj0001156 |
Score | 2.139493 |
Snippet | Higher levels of cysteinyl cathepsin L were detected in human atherosclerotic lesions than in healthy aortas. However, a link between human coronary heart... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 476 |
SubjectTerms | Angina, Unstable - blood Angina, Unstable - diagnostic imaging Biological and medical sciences Biomarkers Biomarkers - blood Blood Glucose - analysis C-Reactive Protein - analysis Cardiology Cardiology. Vascular system Cardiovascular Cardiovascular disease Case-Control Studies Cathepsin L Cathepsins - blood Cigarettes Coronary Angiography Coronary Disease - blood Coronary Disease - diagnostic imaging Coronary heart disease Coronary vessels Cysteine Endopeptidases - blood Female Heart Humans Male Medical imaging Medical sciences Middle Aged Myocardial Infarction - blood Myocardial Infarction - diagnostic imaging Smoking |
Title | Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart Disease |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0002914908018870 https://www.clinicalkey.es/playcontent/1-s2.0-S0002914908018870 https://dx.doi.org/10.1016/j.amjcard.2008.10.011 https://www.ncbi.nlm.nih.gov/pubmed/19195505 https://www.proquest.com/docview/230377137 https://www.proquest.com/docview/66892106 https://pubmed.ncbi.nlm.nih.gov/PMC2752663 |
Volume | 103 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGJiEkNPE5ukHxA69pY8eJ48dRmDrYpglRsTfLcWwt1ZpWTfrAC38758TJKAwN8Rrn0vp8d_6d7guhdzriSovMBIxmScDiGHTORiwIaW7jnAFRM77t_CKZztinq_hqB026WhiXVultf2vTG2vtn4w9N8eronA1viEVxAWuQgKqAn77Ho1EAqK9d3z6eXrRG2QAPUmHgh3BbSHPeD5Si7mGs2izKl2eFyF_u6Ier1QFjLPtxIu7IOnvmZW_XFUnT9C-x5j4uN3GU7Rjymfo4bmPoj9HelYZu7lxRg4vLQZzsVngphRwVRUlPsOqwqrEp_2E3Bq_L5YLl8izxvDCZduLtcLfivoaT1wPBLX-jqegNDX-0EZ8XqDZycevk2nghy0EOolIHbguNSnTTIH_owjPCLchYyqzzOapu9Vzm1GiuM4BwrkJcIQbGmsRGxHnFEDjS7RbLkvzCuFmyJ8Js4jDR6mgKhNxaqzVzLo6WD5ArOOv1L4TuRuIcSO7lLO59MfSTsmEx3AsAzTqyVZtK477CJLu8GRXZwqWUcJlcR8hv4vQVF6_K0lkRWUo_5DBAUp7yi0x_pcfHW7JV79HcNEBNBJg21EncLL_I-BBRpyTCFbf9qtgIVzYR5VmualkkqQCHPtkgA5a4bzlniDCeaiw3y2x7V9wvce3V8riuulBTnkM0C46_P_9HqFHbWSOBiR-jXbr9ca8AYBXZ0P0YPSDDEGNJ1_OLodenX8C-LRRAA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw0JqGBEgI8TnKYPMDr2ljx46TRyhMHbQTD6vYm-U4tpZqTasmfeCF3845TlIKQ0O8xr4kd7473-m-EHqnI6F0mpmA0SwOGOcgczZiQUhzy3MGQM34ttlFPJmzz1f86gCNu1oYl1bZ6n6v0xtt3T4ZtdQcrYvC1fiGNCUucBUSEBXw2-8xEF8nncMfuzwPMHnizgZ223dlPKPFUC0XGk7C51S6LC9C_nZBPVqrCshm_byL2wzS3_Mqf7mozp6gx62Fid97JJ6iA1M-Q_dnbQz9OdLzytjtjVNxeGUxKIvtEjeFgOuqKPEUqwqrEp_383Fr_KFYLV0azwbDhq--E2uFvxX1NR67Dghq8x1PQGRq_NHHe16g-dmny_EkaEctBDqOSB24HjUJ00yB96OIyIiwIWMqs8zmibvTc5tRooTOwYBz89-IMJTrlJuU5xRMxpfosFyV5hXCzYg_E2aRgJfSlKos5YmxVjPrqmDFALGOvlK3fcjdOIwb2SWcLWR7LH5GJjyGYxmgYQ-29o047gKIu8OTXZUp6EUJV8VdgOI2QFO10l1JIisqQ_kHBw5Q0kPuMfG_fPRkj796HMFBB5ORANmOO4aT_Y-A_xgJQSJYPe1XQT-4oI8qzWpbyThOUnDr4wE68sy5o15KUuefAr57bNtvcJ3H91fK4rrpQE4FB8Muev3_-J6iB5PL2VROzy--HKOHPkZHA8LfoMN6szVvwdSrs5NGlH8CPn1QLw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Usefulness+of+serum+cathepsin+L+as+an+independent+biomarker+in+patients+with+coronary+heart+disease&rft.jtitle=The+American+journal+of+cardiology&rft.au=Liu%2C+Yingxian&rft.au=Li%2C+Xiangping&rft.au=Peng%2C+Daoquan&rft.au=Tan%2C+Zheng&rft.date=2009-02-15&rft.eissn=1879-1913&rft.volume=103&rft.issue=4&rft.spage=476&rft_id=info:doi/10.1016%2Fj.amjcard.2008.10.011&rft_id=info%3Apmid%2F19195505&rft.externalDocID=19195505 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029149%2FS0002914908X00384%2Fcov150h.gif |